Protein; Disease
6
1
1
3
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 6 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (6)
Pilot Study on Proteomics of Erythrocyte Proteins in Patients With COPD Based on TMT Technology
Acute Meat and Alternative Intake (PRotEin DIet SatisfacTION Trial 3)
The Proteomic Study and Early Intervention Study of Carotid Unstable Plaque
Proteomics Study of Mild Cognitive Impairment and Alzheimer's Disease
The Biological Basis of Phlegm Dampness Syndrome in Patients With Ischemic Stroke：A Saliva and Urine Proteomics Study
Anabolic Potential of 3-hydroxybutyrate (3-OHB) and Whey Protein in a Human Catabolic Inflammatory Disease Model